Literature DB >> 26611557

Infection Risk and Safety of Corticosteroid Use.

Jameel Youssef1, Shannon A Novosad2, Kevin L Winthrop2.   

Abstract

Corticosteroids are frequently used to treat rheumatic diseases. Their use comes with several well-established risks, including osteoporosis, avascular necrosis, glaucoma, and diabetes. The risk of infection is of utmost concern and is well documented, although randomized controlled trials of short-term and lower-dose steroids have generally shown little or no increased risk. Observational studies from the real world, however, have consistently shown dose-dependent increases in risk for serious infections as well as certain opportunistic infections. In patients who begin chronic steroid therapy, vaccination and screening strategies should be used in an attempt to mitigate this risk.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial infections; Corticosteroids; Opportunistic infections; Rheumatic diseases

Mesh:

Substances:

Year:  2015        PMID: 26611557      PMCID: PMC4751577          DOI: 10.1016/j.rdc.2015.08.004

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  82 in total

1.  Factors influencing discrepancies between the QuantiFERON-TB gold in tube test and the tuberculin skin test in Korean patients with rheumatic diseases.

Authors:  Jae-Hoon Kim; Soo-Kyung Cho; Minkyung Han; Chan-Bum Choi; Tae-Hwan Kim; Jae-Bum Jun; Sang-Cheol Bae; Dae-Hyun Yoo; Yoon-Kyoung Sung
Journal:  Semin Arthritis Rheum       Date:  2012-08-02       Impact factor: 5.532

2.  Antirheumatic drugs and the risk of tuberculosis.

Authors:  Paul Brassard; Abbas Kezouh; Samy Suissa
Journal:  Clin Infect Dis       Date:  2006-08-10       Impact factor: 9.079

Review 3.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

4.  A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.

Authors:  L Guillevin; J F Cordier; F Lhote; P Cohen; B Jarrousse; I Royer; P Lesavre; C Jacquot; P Bindi; P Bielefeld; J F Desson; F Détrée; A Dubois; E Hachulla; B Hoen; D Jacomy; C Seigneuric; D Lauque; M Stern; M Longy-Boursier
Journal:  Arthritis Rheum       Date:  1997-12

5.  Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population.

Authors:  H A Kim; C D Yoo; H J Baek; E B Lee; C Ahn; J S Han; S Kim; J S Lee; K W Choe; Y W Song
Journal:  Clin Exp Rheumatol       Date:  1998 Jan-Feb       Impact factor: 4.473

6.  Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis.

Authors:  Jessica Widdifield; Sasha Bernatsky; J Michael Paterson; Nadia Gunraj; J Carter Thorne; Janet Pope; Alfred Cividino; Claire Bombardier
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

7.  Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.

Authors:  Sanne A A van Dartel; Jaap Fransen; Wietske Kievit; Ellen A J Dutmer; Herman L M Brus; Nella M Houtman; Mart A F van de Laar; Piet L C M van Riel
Journal:  Rheumatology (Oxford)       Date:  2013-01-30       Impact factor: 7.580

8.  Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?

Authors:  Emilio Besada; Johannes C Nossent
Journal:  Clin Rheumatol       Date:  2013-06-11       Impact factor: 2.980

9.  Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.

Authors:  F P Ognibene; J H Shelhamer; G S Hoffman; G S Kerr; D Reda; A S Fauci; R Y Leavitt
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

10.  Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis.

Authors:  E H S Choy; C M Smith; V Farewell; D Walker; A Hassell; L Chau; D L Scott
Journal:  Ann Rheum Dis       Date:  2007-09-03       Impact factor: 19.103

View more
  107 in total

1.  Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.

Authors:  Jianhua Wu; Adam Keeley; Christian Mallen; Ann W Morgan; Mar Pujades-Rodriguez
Journal:  CMAJ       Date:  2019-06-24       Impact factor: 8.262

2.  Inhaled Corticosteroids And Risk Of Tuberculosis In Patients With Obstructive Lung Diseases: A Systematic Review And Meta-Analysis Of Non-randomized Studies.

Authors:  Giorgio Castellana; Marco Castellana; Carlo Castellana; Giuseppe Castellana; Emanuela Resta; Mauro Carone; Onofrio Resta
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-26

3.  Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG.

Authors:  Morgan D McSweeney; Lauren S L Price; Timothy Wessler; Elizabeth C Ciociola; Leah B Herity; Joseph A Piscitelli; Alexander C DeWalle; Taylor N Harris; Andy K P Chan; Ran Sing Saw; Peiqi Hu; J Charles Jennette; M Gregory Forest; Yanguang Cao; Stephanie A Montgomery; William C Zamboni; Samuel K Lai
Journal:  J Control Release       Date:  2019-08-24       Impact factor: 9.776

4.  [Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection].

Authors:  G Tang; L Long; Y X Han; Q Peng; J J Liu; H Shang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

Review 5.  Haematopoietic stem cell transplantation for autoimmune diseases.

Authors:  Joost F Swart; Eveline M Delemarre; Femke van Wijk; Jaap-Jan Boelens; Jürgen Kuball; Jacob M van Laar; Nico M Wulffraat
Journal:  Nat Rev Rheumatol       Date:  2017-02-23       Impact factor: 20.543

Review 6.  Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases.

Authors:  Luis Malpica; Stephan Moll
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

7.  The effect of corticosteroid on postoperative early pain, renal colic and total analgesic consumption after uncomplicated and unstented ureteroscopy: a matched-pair analysis.

Authors:  Nurullah Hamidi; Erdem Ozturk; Taha Numan Yikilmaz; Ali Fuat Atmaca; Halil Basar
Journal:  World J Urol       Date:  2018-02-02       Impact factor: 4.226

8.  Disseminated Neospora caninum infection in a dog with severe colitis.

Authors:  Benjamin Curtis; Adam Harris; Tarini Ullal; Paula A Schaffer; Juan Muñoz Gutiérrez
Journal:  J Vet Diagn Invest       Date:  2020-09-19       Impact factor: 1.279

9.  T Cell Profile After Systemic Steroid Burst in Inner-City Asthmatic Children with Recurrent Infections.

Authors:  Pavadee Poowuttikul; Mohamed Taki; Roula Daher; Elizabeth Secord
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-06-17       Impact factor: 1.349

10.  Complications of Immunosuppression in Glomerular Disease.

Authors:  J Ashley Jefferson
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-24       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.